Milliman Funds ETF (MHIP) Holdings
MHIP holdings summary
as of Oct 25, 2026- Holdings
- 83 positions listed
- Top 10 weight
- 49.5% of net assets
- Effective holdings
- 16 equal-weight equivalent
- Largest holding
- ONEK 12.36% SPDR Russell 1000 ETF
- Annual turnover
- — of the portfolio traded
All MHIP holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | ONEK | SPDR Russell 1000 ETF | Other | 12.36% | $197,884.26 | — | — |
| 2 | LLY | Eli Lilly and Company | Healthcare | 11.57% | $185,219.49 | $1.12T | 42.2 |
| 3 | JNJ | Johnson & Johnson | Healthcare | 5.09% | $81,506.05 | $615.87B | 38.8 |
| 4 | ABBV | AbbVie Inc. | Healthcare | 4.78% | $76,512.20 | $504.37B | 80.6 |
| 5 | XFIV | Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | Other | 3.39% | $54,229.56 | — | — |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 2.91% | $46,667.52 | $255.13B | 37.1 |
| 7 | XHLF | Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | Other | 2.90% | $46,435.36 | — | — |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 2.50% | $40,043.74 | $193.67B | — |
| 9 | AMGN | Amgen Inc. | Healthcare | 2.06% | $32,968.44 | $233.82B | 26.9 |
| 10 | DHR | Danaher Corporation | Healthcare | 1.98% | $31,690.75 | $161.01B | 40.8 |
| 11 | UNH | UnitedHealth Group Incorporated | Healthcare | 1.57% | $25,161.43 | $360.32B | 25.8 |
| 12 | ABT | Abbott Laboratories | Healthcare | 1.56% | $24,959.69 | $181.50B | 33.8 |
| 13 | ISRG | Intuitive Surgical, Inc. | Healthcare | 1.53% | $24,452.14 | $150.74B | 48.9 |
| 14 | PFE | Pfizer Inc. | Healthcare | 1.45% | $23,172.85 | $168.60B | 38.9 |
| 15 | MDT | Medtronic plc | Healthcare | 1.30% | $20,827.23 | $121.20B | 23.3 |
| 16 | CVS | CVS Health Corporation | Healthcare | 1.20% | $19,275.75 | $118.13B | 24.3 |
| 17 | SYK | Stryker Corporation | Healthcare | 1.17% | $18,787.41 | $113.02B | 30.5 |
| 18 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.15% | $18,395.14 | $122.05B | 13.2 |
| 19 | HCA | HCA Healthcare, Inc. | Healthcare | 1.02% | $16,324.91 | $99.34B | 15.4 |
| 20 | MCK | McKesson Corporation | Healthcare | 1.00% | $16,020.70 | $117.15B | 26.9 |
| 21 | NTRA | Natera, Inc. | Healthcare | 0.92% | $14,715.79 | $56.71B | — |
| 22 | ELV | Elevance Health Inc. | Healthcare | 0.81% | $12,944.97 | $92.88B | 19.0 |
| 23 | BSX | Boston Scientific Corporation | Healthcare | 0.78% | $12,567.10 | $64.33B | 18.0 |
| 24 | CI | Cigna Corporation | Healthcare | 0.75% | $11,945.87 | $79.88B | 12.5 |
| 25 | MRK | Merck & Co., Inc. | Healthcare | 0.70% | $11,218.97 | $360.08B | 115.8 |
| 26 | CNC | Centene Corporation | Healthcare | 0.68% | $10,809.09 | $34.16B | — |
| 27 | HUM | Humana Inc. | Healthcare | 0.64% | $10,231.09 | $49.61B | 39.1 |
| 28 | VEEV | Veeva Systems Inc. | Healthcare | 0.60% | $9,549.01 | $50.25B | 50.9 |
| 29 | IQV | IQVIA Holdings Inc. | Healthcare | 0.57% | $9,062.28 | $43.93B | 33.2 |
| 30 | BDX | Becton, Dickinson and Company | Healthcare | 0.56% | $9,020.65 | $52.23B | 44.6 |
| 31 | MDLN | Medline Inc. | Healthcare | 0.55% | $8,881.35 | $48.38B | 89.9 |
| 32 | WAT | Waters Corporation | Healthcare | 0.54% | $8,705.23 | $42.90B | 110.6 |
| 33 | RMD | ResMed Inc. | Healthcare | 0.53% | $8,423.43 | $33.61B | 22.9 |
| 34 | A | Agilent Technologies, Inc. | Healthcare | 0.51% | $8,133.63 | $48.77B | 34.1 |
| 35 | EW | Edwards Lifesciences Corporation | Healthcare | 0.49% | $7,867.85 | $49.92B | 51.5 |
| 36 | COR | Cencora | Healthcare | 0.46% | $7,397.12 | $65.06B | 25.3 |
| 37 | DXCM | DexCom, Inc. | Healthcare | 0.44% | $6,993.64 | $32.47B | 34.1 |
| 38 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.40% | $6,375.62 | $25.94B | 24.6 |
| 39 | ILMN | Illumina, Inc. | Healthcare | 0.39% | $6,186.69 | $39.64B | 49.0 |
| 40 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.37% | $5,994.55 | $25.79B | 26.3 |
| 41 | GH | Guardant Health, Inc. | Healthcare | 0.31% | $4,992.26 | $21.28B | — |
| 42 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.30% | $4,796.92 | $38.14B | — |
| 43 | STE | STERIS plc | Healthcare | 0.24% | $3,786.62 | $21.71B | 27.2 |
| 44 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.23% | $3,671.34 | $31.02B | 39.1 |
| 45 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.22% | $3,519.24 | $32.51B | 36.6 |
| 46 | THC | Tenet Healthcare Corporation | Healthcare | 0.22% | $3,443.99 | $21.52B | 10.5 |
| 47 | RVTY | Revvity, Inc. | Healthcare | 0.21% | $3,395.95 | $17.03B | 73.0 |
| 48 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.20% | $3,240.64 | $27.03B | 49.4 |
| 49 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.20% | $3,150.98 | $17.26B | 36.3 |
| 50 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.20% | $3,139.77 | $14.46B | — |
| 51 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.19% | $3,070.93 | $18.12B | 23.1 |
| 52 | MRNA | Moderna, Inc. | Healthcare | 0.19% | $3,014.89 | $87.04B | — |
| 53 | COO | The Cooper Companies, Inc. | Healthcare | 0.18% | $2,910.82 | $11.02B | 19.9 |
| 54 | SOLV | Solventum Corporation | Healthcare | 0.17% | $2,731.49 | $14.61B | 10.5 |
| 55 | ALGN | Align Technology, Inc. | Healthcare | 0.16% | $2,571.38 | $10.46B | 25.6 |
| 56 | AVTR | Avantor, Inc. | Healthcare | 0.15% | $2,342.42 | $11.11B | — |
| 57 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.15% | $2,337.62 | $13.79B | 19.9 |
| 58 | BIIB | Biogen Inc. | Healthcare | 0.15% | $2,329.61 | $34.37B | 41.3 |
| 59 | TEM | Tempus AI, Inc. | Healthcare | 0.14% | $2,313.60 | $11.68B | — |
| 60 | TECH | Bio-Techne Corporation | Healthcare | 0.14% | $2,297.59 | $11.38B | 62.6 |
| 61 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.14% | $2,284.78 | $31.42B | 16.0 |
| 62 | EHC | Encompass Health Corporation | Healthcare | 0.13% | $2,081.44 | $12.61B | 21.4 |
| 63 | GMED | Globus Medical, Inc. | Healthcare | 0.13% | $2,002.99 | $10.30B | 19.7 |
| 64 | PEN | Penumbra, Inc. | Healthcare | 0.12% | $1,983.77 | $12.64B | 78.8 |
| 65 | DVA | DaVita Inc. | Healthcare | 0.12% | $1,870.10 | $11.95B | 15.8 |
| 66 | UHS | Universal Health Services, Inc. | Healthcare | 0.11% | $1,742.01 | $10.91B | 7.6 |
| 67 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 0.10% | $1,626.73 | $126.66B | 28.9 |
| 68 | BTSG | BrightSpring Health Services, Inc. | Healthcare | 0.10% | $1,610.72 | $12.04B | 53.9 |
| 69 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.10% | $1,573.89 | $81.41B | 19.6 |
| 70 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.08% | $1,338.53 | $11.67B | — |
| 71 | BAX | Baxter International Inc. | Healthcare | 0.08% | $1,301.70 | $13.07B | — |
| 72 | EXEL | Exelixis, Inc. | Healthcare | 0.08% | $1,300.10 | $15.42B | 19.6 |
| 73 | INCY | Incyte Corporation | Healthcare | 0.07% | $1,154.40 | $22.92B | 14.4 |
| 74 | ENSG | The Ensign Group, Inc. | Healthcare | 0.07% | $1,117.57 | $10.29B | 27.7 |
| 75 | NK | NantKwest Inc | Healthcare | 0.07% | $1,077.55 | — | — |
| 76 | RPRX | Royalty Pharma plc | Healthcare | 0.04% | $709.29 | $35.22B | 32.4 |
| 77 | INSM | Insmed Incorporated | Healthcare | 0.03% | $457.92 | $21.02B | — |
| 78 | CAH | Cardinal Health, Inc. | Healthcare | 0.02% | $262.58 | $58.83B | 35.1 |
| 79 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 0.01% | $224.16 | $13.65B | 14.4 |
| 80 | VTRS | Viatris Inc. | Healthcare | 0.01% | $193.73 | $21.43B | — |
| 81 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.01% | $113.68 | $10.58B | 147.8 |
| 82 | CORT | Corcept Therapeutics Incorporated | Healthcare | 0.01% | $108.88 | $11.91B | 244.8 |
| 83 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.00% | $68.85 | $12.98B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($1.6M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
MHIP sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 61.1% | 80 | LLY, JNJ, ABBV |
| Other | 18.6% | 3 | ONEK, XFIV, XHLF |
Sum of the weights of the holdings in each sector.
MHIP top industries
MHIP overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| VHT | Vanguard Health Care ETF | 59.8% | 79 of 406 | 0.10% |
| FHLC | Fidelity MSCI Health Care ETF | 59.7% | 80 of 334 | 0.07% |
| IXJ | iShares Global Healthcare ETF | 54.3% | 56 of 106 | 0.42% |
| RXL | ProShares Ultra Health Care | 51.0% | 56 of 61 | 0.93% |
| MHIG | Milliman Funds ETF | 39.7% | 78 of 79 | — |
| SPY | SPDR S&P 500 ETF | 9.1% | 56 of 502 | 0.09% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the MHIP portfolio
Milliman Funds ETF holds 83 positions. The ten largest make up 49.5% of the fund and the top 50 76.5%, so it behaves like a portfolio of about 16 equally weighted stocks. The biggest positions are SPDR Russell 1000 ETF (12.36%), Eli Lilly and Company (11.57%), Johnson & Johnson (5.09%), AbbVie Inc. (4.78%), Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (3.39%).
By sector, Healthcare is 61.1%, Other is 18.6%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: MHIP chart, MHIP bond profile, MHIP overview.
MHIP holdings FAQ
How many holdings does MHIP have?
MHIP holds 83 positions as of October 25, 2026.
What are the top 10 holdings of MHIP?
The ten largest holdings are SPDR Russell 1000 ETF (12.36%), Eli Lilly and Company (11.57%), Johnson & Johnson (5.09%), AbbVie Inc. (4.78%), Bondbloxx ETF Trust - BondBloxx Bloomberg Five Year Target Duration US Treasury ETF (3.39%), Thermo Fisher Scientific Inc. (2.91%), Bondbloxx ETF Trust - BondBloxx Bloomberg Six Month Target Duration US Treasury ETF (2.90%), Gilead Sciences, Inc. (2.50%), Amgen Inc. (2.06%), Danaher Corporation (1.98%). Together they are 49.5% of the fund.
What percentage of MHIP is SPDR Russell 1000 ETF?
SPDR Russell 1000 ETF is the largest holding at 12.36% of net assets, about $197,884.26 of the fund's $1.6M.
How concentrated is MHIP?
The top 10 holdings are 49.5% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) MHIP behaves like a portfolio of about 16 equally weighted stocks.